North America and Caribbean

Diabetes report 2000 — 2045

Estimates were made for Canada, Mexico, the United States of America and 20 Caribbean countries and territories in the IDF North America and Caribbean (NAC) Region. Estimates for diabetes in adults in the Region were taken from 26 data sources, representing 17 of the 23 countries. Barbados, Canada, Haiti and United Stats of America had studies conducted within the past five years.

NAC Region has the second highest diabetes prevalence among IDF Regions at 14%. IDF projects that the number of people with diabetes in NAC Region will increase 24% reaching 63 million by 2045. The NAC Region has the second highest number of children and adolescents with type 1 diabetes - 193,000 in total. The NAC Region has second highest mortality due to diabetes (931,000) and the second highest percentage (18,4%) of diabetes-related deaths in people of working age among IDF Regions. The NAC Region has the highest diabetes-related expenditure (USD 415 billion) associated with diabetes, 43% of global expenditure. The NAC Region has the highest average cost per person with diabetes (20-79y) - USD 8,208.

Key Messages

An approximate 48 million adults aged 20–79 years are living with diabetes in the IDF North America and Caribbean Region. This represents almost 13% of the regional population in this age group.

Nearly 38% (18 million) of adults aged 20–79 years with diabetes are undiagnosed.

Close to 56 million adults aged 20–79 years have impaired glucose tolerance, about 16% of the regional population in this age group. The North America and Caribbean Region has the highest age-adjusted prevalence of impaired glucose tolerance of all IDF Regions – over 13%.

The North America and Caribbean Region has the second highest number of children and adolescents with type 1 diabetes – almost 225,000 in total. The United States accounts for almost 78% (176,000) of the total.

Health expenditure on diabetes (USD 325 billion) accounts for 43% of the global total – the highest of all IDF Regions. This is estimated to reach USD 339 billion by 2030 and USD 347 billion by 2045.

At a glance	2000	2011	2021	2030	2045
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s	21,375.1	50,547.0	61,425.1	57,000.0	63,000.0
Age-adjusted comparative prevalence of diabetes, %	7.8	10.7	11.9	13.3	14.2
People with undiagnosed diabetes, in 1,000s	-	-	12,224.9	-	-
Proportion of people with undiagnosed diabetes, %	-	-	24.2	-	-